Perrigo Has First US Approval For OTC Omeprazole Mini-Capsule
Executive Summary
Capsule is 70% smaller than tablets of omeprazole currently available in Prilosec OTC and generic equivalents, including formulations Perrigo provides for its private label and store brand customers.
You may also be interested in...
US Q2 Consumer Health Earnings Preview: Horizon Brightens Beyond Current Questions, Challenges?
Consumer health product firms’ vistas include challenges of supply chain disruptions lingering from pandemic’s impact as well as potential for marketplace restrictions as additional varieties of the novel coronavirus spread. Clouds also include shifts in consumer spending, increases in costs caused by inflation and foreign exchange headwinds as the value of the US dollar strengthens against other currencies.
Prevacid 24HR First OTC PPI With Skin Reaction Warning
Lansoprazole along with other OTC and Rx PPI ingredients were linked to a potential risk of acute generalized exanthematous pustulosis FDA in 2019 found a trend in adverse event reports.
Perrigo’s First National Brand, Nasonex OTC Switch, Will Have Familiar Buzz In Advertising
Firm to promote Nasonex 24HR Allergy nasal spray with cartoon bee familiar with brand’s marketing as an Rx product. It doesn't anticipate receiving OTC market exclusivity along with approval of first OTC mometasone furoate product in US.